Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy

OBJECTIVES: Dolutegravir (DTG), a second-generation integrase inhibitor, is an effective treatment for HIV but its safety and efficacy are not well established in pregnancy. Here, we assess maternal and infant outcomes of mother–infant pairs using DTG-containing regimens during pregnancy. METHODS: W...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS
Main Authors: Grayhack, Clara, Sheth, Anandi, Kirby, Olivia, Davis, Jennifer, Sibliss, Kedesha, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Laguerre, Roberta, Rana, Aadia, Badell, Martina, Momplaisir, Florence
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2018
Assuntos:
Clinical Science: Concise Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125741/
https://ncbi.nlm.nih.gov/pubmed/29944472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001931
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares